Handbook of Regenerative Medicine

This book comprehensively reviews cell-free therapy approaches, focusing on the therapeutic potential of mesenchymal stem cell-derived extracellular vesicles (EVs) and secretomes across various reparative and regenerative medicine fields. The initial chapters primarily provide foundational insights into the application of EVs in dentistry, cardiovascular pathologies, and kidney injury. Each chapter discusses the role of mesenchymal stem cell exosomes in targeted therapies for conditions like neurodegenerative disorders, ophthalmological diseases, and diabetes complications, examining the applications of EV-based techniques in personalized medical strategies. The subsequent chapters discuss the advanced diagnostic and therapeutic applications, including using EVs as biomarkers in liquid biopsies and novel tissue engineering and cell-free scaffolding techniques for organ rejuvenation and tissue regeneration. Additionally, this book examines the challenges and progress in transitioning these therapies from laboratory research to clinical applications, covering critical aspects of formulation, Good Manufacturing Practice (GMP) production, regulatory approval, and market access. With insights into emerging technologies like 3D cell scaffolding and theragnostic applications in cancer and neurodegenerative diseases, this book emphasizes the future of a cell-free approach in regenerative medicine. This book is a useful resource for researchers and students in regenerative medicine.

Key Features:

• Provides insights into EV-based therapies and their role in regenerative medicine across multiple medical fields
• Discusses the potential of mesenchymal stem cell-derived exosomes in treating neurodegenerative, ophthalmological, and cardiovascular conditions
• Explores cell-free scaffolding for targeted tissue and organ regeneration
• Reviews the current regulatory, production, and clinical challenges in bringing cell-free therapies to market
• Explores cutting-edge theragnostic applications of EVs in oncology and neurological disorders